Research Analysts’ Updated EPS Estimates for November 17th (ADVM, AKAM, ANRO, ASML, BLD, BLDR, BNTX, BP, BTBT, BVC)

Research Analysts’ updated eps estimates for Monday, November 17th:

Adverum Biotechnologies (NASDAQ:ADVM) had its neutral rating reaffirmed by analysts at HC Wainwright. They currently have a $5.00 target price on the stock, down from their previous target price of $30.00.

Oppenheimer Holdings, Inc. began coverage on shares of Akamai Technologies (NASDAQ:AKAM). Oppenheimer Holdings, Inc. issued an outperform rating and a $100.00 target price on the stock.

BTIG Research initiated coverage on shares of Alto Neuroscience (NYSE:ANRO). They issued a buy rating and a $27.00 target price on the stock.

ASML (NASDAQ:ASML) had its buy rating reiterated by analysts at UBS Group AG.

Wells Fargo & Company began coverage on shares of TopBuild (NYSE:BLD). The firm issued an overweight rating and a $500.00 target price on the stock.

Wells Fargo & Company assumed coverage on shares of Builders FirstSource (NYSE:BLDR). The firm issued an equal weight rating and a $115.00 price target on the stock.

BioNTech (NASDAQ:BNTX) had its buy rating reiterated by analysts at Berenberg Bank.

BP (LON:BP) had its hold rating reaffirmed by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 420 target price on the stock.

Bit Digital (NASDAQ:BTBT) had its buy rating reissued by analysts at HC Wainwright. They currently have a $7.00 target price on the stock.

BATM Advanced Communications (LON:BVC) had its buy rating reiterated by analysts at Shore Capital.

Celcuity (NASDAQ:CELC) had its neutral rating reiterated by analysts at HC Wainwright. The firm currently has a $94.00 target price on the stock, up from their previous target price of $77.00.

Chemring Group (LON:CHG) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a GBX 600 price target on the stock.

Clene (NASDAQ:CLNN) had its buy rating reissued by analysts at D. Boral Capital. D. Boral Capital currently has a $23.00 target price on the stock.

Corebridge Financial (NYSE:CRBG) had its equal weight rating reaffirmed by analysts at Morgan Stanley. They currently have a $33.00 target price on the stock, down from their previous target price of $39.00.

James Cropper (LON:CRPR) had its house stock rating reiterated by analysts at Shore Capital.

Carvana (NYSE:CVNA) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $500.00 price target on the stock.

Dell Technologies (NYSE:DELL) had its underweight rating reissued by analysts at Morgan Stanley. The firm currently has a $110.00 price target on the stock, down from their previous price target of $144.00.

Forte Biosciences (NASDAQ:FBRX) had its buy rating reissued by analysts at Chardan Capital. Chardan Capital currently has a $61.00 target price on the stock.

Figure Technology Solutions (NASDAQ:FIGR) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $51.00 price target on the stock.

Flutter Entertainment (LON:FLTR) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co..

Hoth Therapeutics (NASDAQ:HOTH) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $5.00 price target on the stock.

Hewlett Packard Enterprise (NYSE:HPE) had its equal weight rating reissued by analysts at Morgan Stanley. Morgan Stanley currently has a $25.00 target price on the stock, down from their previous target price of $28.00.

HP (NYSE:HPQ) had its underweight rating reissued by analysts at Morgan Stanley. The firm currently has a $24.00 price target on the stock, down from their previous price target of $26.00.

Wells Fargo & Company initiated coverage on shares of Installed Building Products (NYSE:IBP). They issued an equal weight rating on the stock.

3i Group (LON:III) had its overweight rating reiterated by analysts at JPMorgan Chase & Co..

Inspired Entertainment (NASDAQ:INSE) had its buy rating reaffirmed by analysts at BWS Financial. The firm currently has a $20.00 target price on the stock.

Century Therapeutics (NASDAQ:IPSC) had its market perform rating reiterated by analysts at Leerink Partners. They currently have a $2.00 target price on the stock, down from their previous target price of $7.00.

Jacobs Engineering Group (LON:J) had its house stock rating reiterated by analysts at Shore Capital.

Kodiak Sciences (NASDAQ:KOD) had its neutral rating reissued by analysts at Chardan Capital. The firm currently has a $14.00 price target on the stock.

Land Securities Group (LON:LAND) had its underperform rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 475 price target on the stock.

Land Securities Group (LON:LAND) had its neutral rating reiterated by analysts at JPMorgan Chase & Co..

Liquidity Services (NASDAQ:LQDT) had its outperform rating reiterated by analysts at Barrington Research. Barrington Research currently has a $40.00 target price on the stock.

Bank of America Corporation initiated coverage on shares of Masimo (NASDAQ:MASI). They issued a neutral rating and a $162.00 target price on the stock.

Microsoft (NASDAQ:MSFT) had its buy rating reiterated by analysts at Jefferies Financial Group Inc..

Netflix (NASDAQ:NFLX) had its buy rating reaffirmed by analysts at DZ Bank AG.

NRx Pharmaceuticals (NASDAQ:NRXP) had its buy rating reissued by analysts at D. Boral Capital. The firm currently has a $34.00 price target on the stock.

NVIDIA (NASDAQ:NVDA) had its buy rating reiterated by analysts at JPMorgan Chase & Co..

OS Therapies (NYSEAMERICAN:OSTX) had its buy rating reaffirmed by analysts at D. Boral Capital. D. Boral Capital currently has a $20.00 price target on the stock.

Leerink Partners began coverage on shares of Ovid Therapeutics (NASDAQ:OVID). Leerink Partners issued an outperform rating and a $5.00 target price on the stock.

Palo Alto Networks (NASDAQ:PANW) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $248.00 target price on the stock.

Pacira BioSciences (NASDAQ:PCRX) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $38.00 price target on the stock.

Oppenheimer Holdings, Inc. began coverage on shares of Pure Storage (NYSE:PSTG). The firm issued an outperform rating and a $120.00 target price on the stock.

SAB Biotherapeutics (NASDAQ:SABS) had its buy rating reiterated by analysts at Chardan Capital. Chardan Capital currently has a $12.00 price target on the stock.

Similarweb (NYSE:SMWB) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $14.00 target price on the stock.

Sunoco (NYSE:SUN) had its overweight rating reaffirmed by analysts at Barclays PLC. They currently have a $57.00 target price on the stock.

Suncast Solar Energy (OTCMKTS:SUNC) had its overweight rating reissued by analysts at Barclays PLC. They currently have a $57.00 price target on the stock.

Raymond James Financial, Inc. assumed coverage on shares of Suncast Solar Energy (OTCMKTS:SUNC). The firm issued an outperform rating on the stock.

Value and Indexed Property Income (LON:VIP) had its house stock rating reissued by analysts at Shore Capital.

VolitionRx (NYSE:VNRX) had its buy rating reissued by analysts at D. Boral Capital. The firm currently has a $5.00 price target on the stock.

HC Wainwright started coverage on shares of Vivos Therapeutics (NASDAQ:VVOS). HC Wainwright issued a buy rating and a $7.00 target price on the stock.

Weyerhaeuser (NYSE:WY) had its neutral rating reissued by analysts at Bank of America Corporation. They currently have a $26.00 target price on the stock, down from their previous target price of $29.00.